Interferon-α gene therapy for cancer: Retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models

Gene Therapy

Volumn 4, Issue 10, 1997, Pages 1053-1060

  Tuting T ^a   Gambotto, A ^a   Baar, J ^a   Davis, I D ^a   Storkus, W J ^a   Zavodny, P J ^b   Narula, S ^b   Tahara, H ^a   Robbins, P D ^a   Lotze, M T ^a,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cytokines; Gene therapy; Interferon ; Particle mediated gene transfer; Retroviral vector

Indexed keywords

ALPHA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER; CANCER MODEL; CARCINOGENICITY; CONTROLLED STUDY; DNA TRANSFECTION; FEMALE; FIBROBLAST; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; TUMOR CELL; TUMOR IMMUNITY;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 9844239373     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300509     Document Type: Article

References (41)

1. Tepper RI, Mule JJ. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 1994; 5: 153-164.
2. Pardoll DM. Paracrine cytokine adjuvants in cancer immuno-therapy. Annu Rev Immnnol 1995; 13: 399-415.
3. Tahara H et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J Immunol 1995; 154: 6466-6474.
4. Belardelli F, Gresser I. The neglected role of type I interferon in T cell response: implications for its clinical use. Immunol Today 1996; 17: 369-372.
5. Ferrantini M et al α1-Interferon gene transfer into metastatic friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Cancer Res 1993; 53: 1107-1112.
6. + T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma producing TS/A cells. J Immunol 1994; 153: 4604-4615.
7. Kaido T et at. IFN-α1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice. Int J Cancer 1995; 60: 221-229.
8. Sarkar S et al. Injection of irradiated B16 melanoma genetically modified to secrete IFN-α causes regression of an established tumor. Int J Oncol 1995; 7: 17-24.
9. Santodonato L et al. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-a1 and herpes simplex thymidine kinase followed by gancyclovir. Hum Gene Ther 1996; 7: 1-10.
10. + blood dendritic cells are potent producers of IFN-α in response to in vitro HIV-1 infection. J Immunol 1994; 152: 4649-4662.
11. Fitzgerald-Bocarsly P. Human natural interferon-α producing cells. Pharmac Ther 1993; 60: 39-62.
12. Eloranta M-L, Sandberg K, Alm GV. The interferon-α responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and in vivo. Scand J Immunol 1996; 43: 355-360.
13. Svensson H et al. The cell surface phenotype of human natural interferon-α producing cells as determined by flow cytometry. Scand J Immunol 1996; 44: 164-172.
14. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995; 103: 161-179.
15. Rogge L et al. Selective expression of an interleukin-12 receptor component by human T helper cells. J Exp Med 1997; 185: 825-831.
16. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272: 1947-1950.
17. Belldegrun A et al. Human renal carcinoma line transfected with interleukin-2 and/or interferon α gene(s): implications for live cancer vaccines. J Natl Cancer Inst 1993; 85: 207-216.
18. Hathorn RW et al. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon α gene transfer. Cancer 1994; 74: 1904-1911.
19. Gutterman JU. Cytokine therapeutics: lessons from interferon α-Proc Natl Acad Sci USA 1994; 91: 1198-1205.
20. Parmiani G, Colombo MP, Melani C, Arienti F. Cytokine gene-transduction in the immunotherapy of cancer. Adv Pharmacol (in press).
21. Tahara H et al. Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce anti-tumor immunity to a murine melanoma in vivo. Cancer Res 1994; 54: 182-189.
22. Zitvogel L et al. Cancer immunotherapy of established tumors with interleukin-12 (IL-12): effective delivery by genetically engineered fibroblasts. J Immunol 1995; 155: 1393-1403.
23. Tahara H et al. Clinical protocol: IL-12 gene therapy using direct injections of tumors with genetically engineered autologous fibroblasts. Hum Gene Ther 1995; 6: 1607-1624.
24. Elder EM, Lotze MT, Whiteside TL. Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biological therapy of patients with cancer. Hum Gene Ther 1996; 7: 479-487.
25. Yang N-S, Sun WH. Gene gun and other non-viral approaches for cancer gene therapy. Nature Med 1995; 1: 481-483.
26. Rakhmilevich AL et al. Gene gun-mediated skin transfection with interleukin-12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci USA 1996; 93: 6291-6296.
27. Mahvi DM et al. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum Gene Ther 1996; 7: 1535-1543.
28. Albertini MR et al. Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer. Cancer Gene Ther 1996; 3: 192-201.
29. Danos O, Mulligan R. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460-6464.
30. Pear W, Nolan G, Scott M, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392-8396.
31. Zatloukal JM et al. Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. J Immunol 1995; 154: 3406-3419.
32. Leimig T et al. High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors. Hum Gene Ther 1996; 7: 1233-1239.
33. Zhang JF et al Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy. Proc Natl Acad Sci USA 1996; 93: 4513-4518.
34. Zhang JF et al. Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression. Cancer Gene Ther 1996; 3: 31-38.
35. Toloza EM et al. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther 1996; 3: 11-17.
36. Ju DW, Cao X, Acres B. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a murine melanoma model. Cancer Gene Ther 1997; 4: 139-144.
37. Caruso M et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA 1996; 93: 11302-11306.
38. Bramson JL et al. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum Gene Ther 1996; 7: 333-342.
39. Bramson JL et al. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum Gene Ther 1996; 7: 1995-2002.
40. Meko JB, Yim JH, Tsung K, Norton JA. High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12. Cancer Res 1996; 55: 4765-4770.
41. Zitvogel L et al. Construction and characterization of retroviral vectors expressing biologically active human interleukin 12. Hum Gene Ther 1994; 5: 1493-1506.